Pham Quang X 4/A
4/A · Cadrenal Therapeutics, Inc. · Filed Mar 24, 2025
Insider Transaction Report
Form 4/AAmended
Pham Quang X
DirectorCEO and Chairman10% Owner
Transactions
- Award
Stock Options
2025-01-23+65,000→ 65,000 totalExercise: $19.79From: 2026-02-01Exp: 2035-01-22→ Common Stock (65,000 underlying)
Footnotes (1)
- [F1]This amendment to Form 4 is being filed to correct the exercise price and the expiration date of the stock option, which were incorrectly reported on the original Form 4 filed by the Reporting Person on January 24, 2025 (the "Original Form 4"). The exercise price of the stock option is equal to 100% of the fair market value of the Issuer's common stock on the effective date of the grant and the stock option expires ten years from the date of issuance. The stock option vests according to the vesting schedule as previously reported on the Original Form 4.